2 active not recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Eye Abnormalities: new trials by email Literature Review of Eye Abnormalities trials Research Report on Eye Abnormalities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene Intravitreal Injection of Ultevursen, No intervention, will not receive any active study intervention - Retinitis Pigmentosa (RP), Usher Syndrome Type 2 | Phase 2 | Active not recruiting | Laboratoires Thea | 81 | 2024-12-11 | 2026-07-09 |
| A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE) sepofarsen, Sham - Leber Congenital Amaurosis 10, Blindness | Phase 2 / Phase 3 | Active not recruiting | ProQR Therapeutics | 36 | 2019-04-04 | 2022-03-17 |
Eye Diseases, Hereditary (2) · Retinal Diseases (2) · Vision Disorders (2) · Blindness (1) · Eye Diseases (1) · Leber Congenital Amaurosis (1) · Leber Congenital Amaurosis 10 (1) · Meckel Syndrome, Type 4 (1) · Neurologic Manifestations (1) · Optic Atrophy, Hereditary, Leber (1) · Retinitis Pigmentosa (1) · Sensation Disorders (1) · Usher Syndromes (1)
Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Nervous System Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Abnormalities, Multiple (1) · Blindness (1) · Cranial Nerve Diseases (1) · Deaf-Blind Disorders (1) · Deafness (1) · Ear Diseases (1) · Eye Diseases (1) · Hearing Disorders (1) · Hearing Loss (1)
Laboratoires Thea (1) · ProQR Therapeutics (1)
Belgium (2) · Brazil (2) · Canada (2) · France (2) · Germany (2) · Italy (2) · Netherlands (2) · United Kingdom (2) · United States (2) · Denmark (1)
2018 (1)